Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Promega introduces the GloMax® Galaxy Bioluminescence Imager to illuminate protein dynamics in real time

or altering the physiological state. Implementing bioluminescence imaging in a workflow enhances disease modeling and pharmaceutical candidate screening efforts by providing clearer, real-time insights into how cells and proteins behave in...

BioCare collaborates with AeroSafe Global to introduce sustainable cold chain solutions

BioCare, a leader in specialty pharmaceutical distribution, is excited to announce its new partnership with AeroSafe Global, a pioneer in reliable, sustainable cold chain solutions. This collaboration introduces an innovative, reusable...

LenioBio partners with ReciBioPharm to scale up ALiCE® technology and accelerate vaccine production

for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. Led by a management team and technical experts with a...

Doer Biologics announces the dosing of the first patient in a Phase 2 study of DR10624 for severe hypertriglyceridemia treatment.

Zhejiang Doer Biologics Co., Ltd. a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, announces that DR10624, its first-in-class (FIC), tri-specific agonist targeting Fibroblast...

Galmed releases Phase 3 Aramchol results in Hepatology.

Galmed Pharmaceuticals Ltd. a clinical-stage biopharmaceutical company for liver, metabolic and fibro-inflammatory diseases announced that the one-year results of the Open-Label part (ARCON ) of its global Phase 3 trial of Aramchol in 150 patients...

EydisBio receives FDA Orphan Drug Designation for its TAK1 inhibitor to treat systemic sclerosis.

and potent, orally bioavailable TAK1 inhibitor for the treatment of systemic sclerosis. EydisBio is an early-stage pharmaceutical company leveraging a novel approach to treating various autoimmune and inflammatory diseases, including rare diseases....

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

Beach, has announced a partnership between their new comprehensive assessment and research center, nuHx, and Marius Pharmaceuticals, the company behind KYZATREX® (testosterone undecanoate) CIII capsules, an FDA-approved oral testosterone treatment...

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

trial advances, providing a faster and more cost-effective path toward potential approval and/or partnerships with pharmaceutical companies. "We are excited to unveil our Phase 2 study plan, bringing us one step closer to a potentially...

Restore Hyper Wellness has partnered with MECOTEC to enhance their offerings in cryotherapy solutions.

first cryo-chamber was built in 1995) to a world leader in high-tech cooling solutions. MECOTEC offers expertise in pharmaceutical and industrial applications as well as electric cryo-chambers for fitness, wellness and sports. The company provides...

2nd Global Summit on Pharmaceutical and Medicinal Chemistry 2024

2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during September 23,25, 2024. 2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during...

Biotech Congress 2024

such as renewable energy, food, agriculture, health-care, biodegradable polymers, biofertilizers, biopesticides, biopharmaceuticals, commodity and fine chemicals etc.

The American Kidney Fund's Rare Kidney Disease Advocacy Day on Capitol Hill aims to gather support for legislation to boost awareness and treatment of rare kidney diseases.

kidney disease." AKF is grateful to the sponsors of the RKDAN whose support helps make this event possible: Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Inc. and Travere Therapeutics. About the American Kidney Fund: The...

Swiss startup Enzian Pharmaceutics is developing a new tablet aimed at enhancing effectiveness and reducing side effects in cancer therapies

The capsules and tablets commonly used today consist of loose or lightly compressed particles of the drug and excipients. After ingestion, they disintegrate almost immediately in the stomach. The small drug particles then flow from the stomach and...

ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.

a focus on healthy aging, is excited to announce the second wave of intravenous (IV) wellness clinics that will offer pharmaceutical-grade Niagen® (nicotinamide riboside chloride or NRC), branded Niagen+, in intravenous (IV) and injectable forms....

Zydus announces an exclusive licensing and supply agreement for two Gadolinium-based MRI injectable contrast agents in the U.S

subsidiary, Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals (Viwit), an innovation driven biopharmaceutical and healthcare company, for gadobutrol injection (generic version of...

City of Hope and BRC treat first patient with BRC-001 in a breast cancer care trial.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, and Biopharmaceutical Research Company (BRC), a specialty pharmaceutical company developing proprietary cannabinoid therapeutics, announced that...

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

global customers. Today, Bloomage's raw materials are integral to the product lines of numerous well-established pharmaceutical, personal care, and health food companies worldwide. "2024 is a year of success for Bloomage as our international market...

Solu Therapeutics appoints Sergio Santillana, MD, as Chief Medical Officer to strengthen its leadership team.

and Japan. In his career, Dr. Santillana has held the role of Chief Medical Officer at Ikena Oncology, Merrimack Pharmaceuticals and Ariad Pharmaceuticals, and had various leadership roles at Eli Lilly, GlaxoSmithKline and Takeda Pharmaceuticals....

Aptar Pharma signs an exclusive agreement with Pulmotree to develop and promote the Kolibri™ non-propellant liquid inhaler platform

from formulation development to patient onboarding.” Ulf Krüger, CEO of PULMOTREE, stated, “With this alliance, pharmaceutical partners can access an unprecedented portfolio of services from Aptar Pharma as a single source, in the development of...

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AISA-021(cilnidipine), a fourth-generation calcium channel antagonist. Aisa is...